awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33265964-CA20CACC-CE8E-4150-8FCA-625C31A369C1
Q33265964-CA20CACC-CE8E-4150-8FCA-625C31A369C1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33265964-CA20CACC-CE8E-4150-8FCA-625C31A369C1
A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer.
P2860
Q33265964-CA20CACC-CE8E-4150-8FCA-625C31A369C1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33265964-CA20CACC-CE8E-4150-8FCA-625C31A369C1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3bff2a511fe833b5192c6d575e37327a46fee9ad
P2860
Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell'Italia Meridionale.